This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jenum, P. A.
Right arrow Articles by Stray-Pedersen, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jenum, P. A.
Right arrow Articles by Stray-Pedersen, B.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, October 1998, p. 2907-2913, Vol. 36, No. 10
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Development of Specific Immunoglobulins G, M, and A Following Primary Toxoplasma gondii Infection in Pregnant Women

Pål A. Jenum1,* and Babill Stray-Pedersen2

Department of Bacteriology, National Institute of Public Health,1 and Department of Gynecology and Obstetrics, National Hospital,2 Oslo, Norway

Received 30 December 1997/Returned for modification 8 April 1998/Accepted 13 July 1998

The development of specific antibodies following primary Toxoplasma gondii infection during pregnancy was assessed by six different antibody assays: dye test, Platelia Toxo-IgG, Toxo-Screen DA IgG, Platelia Toxo-IgM, Toxo-ISAGA IgM, and Platelia Toxo-IgA. A total of 126 sera from 27 pregnant women, for whom the time of acquisition of infection could be estimated fairly accurately, were included. All tests showed great individual variation in the peak amounts of antibodies detected. The times elapsed after infection until the peak was reached also varied greatly from individual to individual: the ranges were 2 to 21 weeks for the dye test, 4 to 36 weeks for Platelia Toxo-IgG, 4 to 30 weeks for Toxo-Screen DA IgG, 2 to 18 weeks for Platelia Toxo-IgM, 1 to 6 weeks for Toxo-ISAGA IgM, and 2 to 21 weeks for Platelia Toxo-IgA. In the early phase of the infection the dye test and the specific-IgM tests were the most sensitive. Toxo-Screen DA IgG was more sensitive than Platelia Toxo-IgG in the acute phase, while Platelia Toxo-IgA was clearly the least sensitive assay. Of the sera collected 21 to 52 weeks after infection, all were positive by the dye test, all except one (which was negative by Platelia Toxo-IgG) were positive by the specific-IgG tests, approximately 80% were positive by the IgM tests, and 45% were positive by the IgA test. Due to the great individual variation it seems impossible to estimate when the infection occurred based on results obtained from a single serum, and it may even be difficult to assess when a titer increase in paired sera is detectable unless the first sample is only marginally positive. As a diagnostic criterion a dye test titer of >= 300 IU/ml has a low sensitivity for recent primary infection.

* Corresponding author. Mailing address: Department of Bacteriology, National Institute of Public Health, P.O. Box 4404 Torshov, 0403 Oslo, Norway. Phone: (47) 22 04 22 00. Fax: (47) 22 04 25 18.

Journal of Clinical Microbiology, October 1998, p. 2907-2913, Vol. 36, No. 10
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Franck, J., Garin, Y. J.-F., Dumon, H. (2008). LDBio-Toxo II Immunoglobulin G Western Blot Confirmatory Test for Anti-Toxoplasma Antibody Detection. J. Clin. Microbiol. 46: 2334-2338 [Abstract] [Full Text]  
  • Calderaro, A., Piccolo, G., Peruzzi, S., Gorrini, C., Chezzi, C., Dettori, G. (2008). Evaluation of Toxoplasma gondii Immunoglobulin G (IgG) and IgM Assays Incorporating the New Vidia Analyzer System. CVI 15: 1076-1079 [Abstract] [Full Text]  
  • Pfrepper, K.-I., Enders, G., Gohl, M., Krczal, D., Hlobil, H., Wassenberg, D., Soutschek, E. (2005). Seroreactivity to and Avidity for Recombinant Antigens in Toxoplasmosis. CVI 12: 977-982 [Abstract] [Full Text]  
  • Petersen, E., Borobio, M. V., Guy, E., Liesenfeld, O., Meroni, V., Naessens, A., Spranzi, E., Thulliez, P. (2005). European Multicenter Study of the LIAISON Automated Diagnostic System for Determination of Toxoplasma gondii-Specific Immunoglobulin G (IgG) and IgM and the IgG Avidity Index. J. Clin. Microbiol. 43: 1570-1574 [Abstract] [Full Text]  
  • Aubert, D., Maine, G. T., Villena, I., Hunt, J. C., Howard, L., Sheu, M., Brojanac, S., Chovan, L. E., Nowlan, S. F., Pinon, J. M. (2000). Recombinant Antigens To Detect Toxoplasma gondii-Specific Immunoglobulin G and Immunoglobulin M in Human Sera by Enzyme Immunoassay. J. Clin. Microbiol. 38: 1144-1150 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»